Phase II study of gemcitabine (GEM) plus sirolimus (SIR) in previously treated patients with advanced soft tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
暂无分享，去创建一个
N. Mulet-Margalef | J. López-Martín | J. Broto | A. Redondo | A. López-pousa | J. Lavernia | X. Sanjuán | R. Cubedo | X. G. Muro | J. Martínez-Trufero | Ò. M. Tirado